Wire Stories
CMIC Group Supports Clinical Trials and Manufacturing of Influenza Antiviral Drug �Avigan� Tablet� and Contributes to Accelerating Provision for COVID-19 Patients
TOKYO–(BUSINESS WIRE)–#Avigan–CMIC HOLDINGS Co., Ltd. (Head Office: Tokyo, Minato-ku, Representative Director & CEO Kazuo Nakamura, hereafter “CMIC”) announced today that CMIC is...